⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

REGN

Regeneron Pharmaceuticals, Inc.

Healthcare · Biotechnology

805.02USD

-14.0700 (-1.72%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on REGN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 805.02
P/E19.1
Dvd Ind Yld0.5%
P/B2.61
P/S5.3
Curr EV/T12M EBITDA17.2
Mkt Cap (USD)82.9B
Curr EV (USD)75.1B
2)

Per Share Data

EPS T12M40.38
DPS3.57
Bk Val Per Sh316.11
Rev/Sh146.55
Cash/Sh80.06
Curr Shares Out101.1M
FCF/Sh35.48
3)

Cash Flow Analysis

P/CF17.7
Curr P/FCF22.0
CF/NI1.1
Dvd P/O8.7%
Cash Gen/Cash Reqd3.6
Csh Dvd Cov12.4
CFO/Sales30.1%
Eff Interest Rate2.8%
4)

Growth Potential

Dil EPS 1Y Gr8.2%
Cap 1Y Gr6.1%
BPS 1Y Gr12.9%
R&D To Sales40.4%
Retention Rate91.3%
Rev 1Y Gr1.0%
FCF 1Y Gr11.3%
Assets 1Y Gr7.4%
5)

Profitability

EBITDA4.4B
EBIT3.8B
Operating Margin24.7%
Pretax Margin33.3%
Net Margin27.9%
ROA10.8%
ROE14.0%
ROC9.1%
Asset Turnover0.39
6)

Structure

Current Ratio3.34
Quick Ratio2.63
Debt/Assets8.4%
Debt/Com Eq11.0%
Net Debt/EBITDA0.24
Tot Debt/Capital9.9%
Gross Margin37.7%
EBIT/Int Exp69.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.